Prolonged recombinant activated factor VII (rFVIIa) treatment for severe bleeding in a factor-IX-deficient patient with an inhibitor. Br J Haematol 1991 Jul;78(3):460-3
Date
07/01/1991Pubmed ID
1873233DOI
10.1111/j.1365-2141.1991.tb04468.xScopus ID
2-s2.0-0025797762 (requires institutional sign-in at Scopus site) 19 CitationsAuthor List
Schmidt ML, Smith HE, Gamerman S, DiMichele D, Glazer S, Scott JPMESH terms used to index this publication - Major topics in bold
ChildCompartment Syndromes
Drug Administration Schedule
Factor IX
Factor VIIa
Hemophilia B
Hemorrhage
Humans
Immunoglobulin G
Male
Recombinant Proteins
